+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Onychomycosis Clinical Trial Pipeline Highlights - 2021

  • ID: 5236243
  • Report
  • January 2021
  • Region: Global
  • Fore Pharma
1 of 3
The latest report Onychomycosis Pipeline Highlights - 2021, provides the most up-to-date information on key pipeline products in the global Onychomycosis market. It covers emerging therapies for Onychomycosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Onychomycosis pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Onychomycosis pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Onychomycosis pipeline products by the company.

Short-term Launch Highlights:
Find out which Onychomycosis pipeline products will be launched in the US and Ex-US till 2025.

SUMMARY:
  • Onychomycosis phase 3 clinical trial pipeline products
  • Onychomycosis phase 2 clinical trial pipeline products
  • Onychomycosis phase 1 clinical trial pipeline products
  • Onychomycosis preclinical research pipeline products
  • Onychomycosis discovery stage pipeline products
  • Onychomycosis pipeline products short-term launch highlights
Note: Product cover images may vary from those shown
2 of 3
1. Onychomycosis Pipeline by Stages
2. Onychomycosis Phase 3 Clinical Trial Insights
3. Onychomycosis Phase 2 Clinical Trial Insights
4. Onychomycosis Phase 1 Clinical Trial Insights
5. Onychomycosis Preclinical Research Insights
6. Onychomycosis Discovery Stage Insights
7. Appendix
8. Research Methodology

List of Tables
Table 1: Onychomycosis Phase 3 Clinical Trials, 2021
Table 2: Onychomycosis Phase 2 Clinical Trials, 2021
Table 3: Onychomycosis Phase 1 Clinical Trials, 2021
Table 4: Onychomycosis Preclinical Research, 2021
Table 5: Onychomycosis Discovery Stage, 2021

List of Figures
Figure 1: Onychomycosis Pipeline Molecules by Clinical Trials Stage, 2021
Figure 2: Onychomycosis Phase 3 Clinical Trial Highlights, 2021
Figure 3: Onychomycosis Phase 2 Clinical Trial Highlights, 2021
Figure 4: Onychomycosis Phase 1 Clinical Trial Highlights, 2021
Figure 5: Onychomycosis Preclinical Research Highlights, 2021
Figure 6: Onychomycosis Discovery Stage Highlights, 2021
Note: Product cover images may vary from those shown
3 of 3
  • Global
  • Europe
  • US
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Japan
Note: Product cover images may vary from those shown
Adroll
adroll